Pharmaceutical Executive Digital Edition - February 2011
The Promise Of Translational Medicine
Skipping the Needle: Pharm Exec's Brand of the Year
Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story
Honing Reforms from Clinical Development
Increased efficiency and lower operating costs for both CROs and vendors can be achieved by eliminating activities
Growing Stronger After the Storm
To manage through a resource-constrained environment, it is essential to get the most out of procurement planning
